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Abstract
Eradication of immunologically-syngeneic tumors was achieved by adoptive chemotherapy
using effector cells induced by Corynebacterium parvum-Pyridine Extract Residue (CP-PER). A
mixture of 2 X 10(6) Meth A cells and 0.1 mg CP-PER was subcutaneously inoculated into the
back of donor BALB/c mice, with the result that their spleen cells showed an antitumor effect 10
to 13 days after the inoculation. These cells were used as immune cells. Recipient mice were
inoculated with 1 X 10(6) Meth A cells, and 2 days later were administered cyclophosphamide.
On the following day, 1 X 10(8) immune cells were adoptively transferred into the recipient mice.
As a result, the tumor began to regress 7 to 12 days after the adoptive transfer. An immuno-
histochemical study of the donors’ spleens and the recipients’ regressing tumors revealed that the
ratio of L3T4+ T cells to Lyt-2+ T cells in the donors’ spleens was increased and that the infiltrating
cells in the recipients’ tumors were mainly composed of L3T4+ T cells. This confirmed that the
transfer of L3T4+ T cells led to the infiltration of L3T4+ T cells into the recipients’ tumors, causing
their eradication.
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